Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Conditions
Brain and Central Nervous System Tumors
What is the purpose of this trial?
RATIONALE: Sometimes a tumor may not need treatment until it progresses. In this case, observation may be sufficient. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor, such as 3-dimensional conformal radiation therapy and intensity-modulated radiation therapy, may kill more tumor cells and cause less damage to normal tissue. It is not yet known whether observation is more effective than radiation therapy in treating patients with meningioma.
PURPOSE: This phase II trial is studying observation to see how well it works compared with radiation therapy in treating patients with grade I, grade II, or grade III meningioma.
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- National Cancer Institute (NCI)
Radiation Therapy Oncology Group - Dates:
- June 2009
- Last Updated:
- April 6, 2011
- Study HIC#:
- 1007007089
Clinicaltrials.gov ID: NCT00895622




